Systemic lupus erythematosus and Enterocolitis

Summary:

Enterocolitis is found among people with Systemic lupus erythematosus, especially for people who are female, 60+ old.

The study analyzes which people have Enterocolitis with Systemic lupus erythematosus. It is created by eHealthMe based on reports of 36 people who have Systemic lupus erythematosus from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Systemic lupus erythematosus?

Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) is found to be associated with 1,087 drugs and 1,646 conditions by eHealthMe. Check the latest studies of Systemic lupus erythematosus.

What is Enterocolitis?

Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon) is found to be associated with 660 drugs and 732 conditions by eHealthMe. Check the latest studies of Enterocolitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

36 people who have Systemic Lupus Erythematosus and Enterocolitis are studied.

Would you have Enterocolitis when you have Systemic lupus erythematosus?

Gender of people who have Systemic Lupus Erythematosus and experienced Enterocolitis *:

  • female: 86.67 %
  • male: 13.33 %

Age of people who have Systemic Lupus Erythematosus and experienced Enterocolitis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 26.09 %
  • 30-39: 8.7 %
  • 40-49: 30.43 %
  • 50-59: 4.35 %
  • 60+: 30.43 %

Common co-existing conditions for these people *:

  1. Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 4 people, 11.11%
  2. Vaginal Infection: 2 people, 5.56%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.56%
  4. Birth Control: 2 people, 5.56%
  5. Colitis (inflammation of colon): 2 people, 5.56%
  6. Colon Cancer Metastatic (cancer of colon spreads to other part of body): 2 people, 5.56%
  7. Constipation: 2 people, 5.56%
  8. Diarrhea: 2 people, 5.56%
  9. Drug Level Increased: 2 people, 5.56%
  10. Epicondylitis (tennis elbow): 2 people, 5.56%

Common drugs taken by these people *:

  1. Nexium: 13 people, 36.11%
  2. Plaquenil: 12 people, 33.33%
  3. Cellcept: 11 people, 30.56%
  4. Prograf: 7 people, 19.44%
  5. Benlysta: 5 people, 13.89%
  6. Prednisolone: 4 people, 11.11%
  7. Pantoprazole: 4 people, 11.11%
  8. Folic Acid: 4 people, 11.11%
  9. Prednisone: 4 people, 11.11%
  10. Carboplatin: 4 people, 11.11%

Common symptoms for these people *:

  1. Dyslipidaemia (abnormal amount of lipids): 6 people, 16.67%
  2. Diarrhea: 6 people, 16.67%
  3. Dizziness: 5 people, 13.89%
  4. Herpes Zoster: 5 people, 13.89%
  5. Upper Respiratory Tract Inflammation: 5 people, 13.89%
  6. The Flu (the flu is caused by an influenza virus): 5 people, 13.89%
  7. Neuralgia (pain in one or more nerves): 5 people, 13.89%
  8. Periodontitis (inflammation of the tissue around the teeth): 5 people, 13.89%
  9. Insomnia (sleeplessness): 4 people, 11.11%
  10. Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 3 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Enterocolitis?

- Check whether Enterocolitis is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Enterocolitis:

All the conditions that are associated with Enterocolitis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Enterocolitis and Systemic lupus erythematosus, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: